Portal glucose infusion-glucose clamp measures hepatic influence on postprandial systemic glucose appearance as well as whole body glucose disposal

American Journal of Physiology - Endocrinology and Metabolism

Volumn 298, Issue 2, 2010, Pages

  Zheng, Dan ^a   Ionut, Viorica ^a   Mooradian, Vahe ^a   Stefanovski, Darko ^a   Bergman, Richard N ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Addition; Glucose; Hepatic; Net

Indexed keywords

GLUCOSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DOG; GLUCONEOGENESIS; GLUCOSE CLAMP TECHNIQUE; GLUCOSE INFUSION; GLUCOSE METABOLISM; HYPERGLYCEMIA; HYPERINSULINEMIA; INSULINEMIA; LIVER; MALE; NONHUMAN; PORTAL VEIN; POSTPRANDIAL STATE; PRIORITY JOURNAL; RODENT; STEADY STATE; SWINE; VEIN CATHETERIZATION;

ANIMALS; BLOOD GLUCOSE; DOGS; ENERGY METABOLISM; GLUCOSE CLAMP TECHNIQUE; HOMEOSTASIS; INFUSIONS, INTRAVENOUS; LIVER; MALE; PORTAL VEIN; POSTPRANDIAL PERIOD;

EID: 74949125613     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00280.2009     Document Type: Article

References (53)

1. Abumrad NN, Cherrington AD, Williams PE, Lacy WW, Rabin D. Absorption and disposition of a glucose load in the conscious dog. Am J Physiol Endocrinol Metab 242: E398-E406, 1982.
2. Ader M, Ni TC, Bergman RN. Glucose effectiveness assessed under dynamic and steady state conditions. Comparability of uptake versus production components. J Clin Invest 99: 1187-1199, 1997.
3. Barrett EJ, Ferrannini E, Gusberg R, Bevilacqua S, DeFronzo RA. Hepatic and extrahepatic splanchnic glucose metabolism in the postabsorptive and glucose fed dog. Metabolism 34: 410-420, 1985.
4. Bergman RN, Beir JR, Hourigan PM. Intraportal glucose infusion matched to oral glucose absorption. Lack of evidence for "gut factor" involvement in hepatic glucose storage. Diabetes 31: 27-35, 1982.
5. Bergman RN, Hope ID, Yang YJ, Watanabe RM, Meador MA, Youn JH, Ader M. Assessment of insulin sensitivity in vivo: a critical review. Diabetes Metab Rev 5: 411-429, 1989.
6. Berthoud HR, Kressel M, Neuhuber WL. An anterograde tracing study of the vagal innervation of rat liver, portal vein and biliary system. Anat Embryol (Berl) 186: 431-442, 1992.
7. Bradley DC, Steil GM, Bergman RN. OOPSEG: a data smoothing program for quantitation and isolation of random measurement error. Comput Methods Programs Biomed 46: 67-77, 1995.
8. Burcelin R, Dolci W, Thorens B. Portal glucose infusion in the mouse induces hypoglycemia: evidence that the hepatoportal glucose sensor stimulates glucose utilization. Diabetes 49: 1635-1642, 2000.
9. Butler PC, Rizza RA. Contribution to postprandial hyperglycemia and effect on initial splanchnic glucose clearance of hepatic glucose cycling in glucose-intolerant or NIDDM patients. Diabetes 40: 73-81, 1991.
10. Cersosimo E, Garlick P, Ferretti J. Renal glucose production during insulin-induced hypoglycemia in humans. Diabetes 48: 261-266, 1999.
11. Cherrington AD, Stevenson RW, Steiner KE, Davis MA, Myers SR, Adkins BA, Abumrad NN, Williams PE. Insulin, glucagon, and glucose as regulators of hepatic glucose uptake and production in vivo. Diabetes Metab Rev 3: 307-332, 1987.
12. Dardevet D, Moore MC, Neal D, DiCostanzo CA, Snead W, Cherrington AD. Insulin-independent effects of GLP-1 on canine liver glucose metabolism: duration of infusion and involvement of hepatoportal region. Am J Physiol Endocrinol Metab 287: E75-E81, 2004.
13. DeFronzo RA, Ferrannini E, Hendler R, Felig P, Wahren J. Regulation of splanchnic and peripheral glucose uptake by insulin and hyperglycemia in man. Diabetes 32: 35-45, 1983.
14. Felig P, Wahren J, Hendler R. Influence of oral glucose ingestion on splanchnic glucose and gluconeogenic substrate metabolism in man. Diabetes 24: 468-475, 1975.
15. Ferrannini E, Simonson DC, Katz LD, Reichard G, Jr, Bevilacqua S, Barrett EJ, Olsson M, DeFronzo RA. The disposal of an oral glucose load in patients with non-insulin-dependent diabetes. Metabolism 37: 79-85, 1988.
16. Finegood DT, Bergman RN, Vranic M. Estimation of endogenous glucose production during hyperinsulinemic-euglycemic glucose clamps. Comparison of unlabeled and labeled exogenous glucose infusates. Diabetes 36: 914-924, 1987.
17. Georg P, Kautzky-Willer A, Mahdjoobian K, Hofer A, Prager R, Pacini G, Ludvik BH. Influence of metabolic control on splanchnic glucose uptake, insulin sensitivity, and the time required for glucose absorption in patients with type 1 diabetes. Diabetes Care 25: 2042-2047, 2002.
18. Gervaz P, Scholl B, Gillet M. Permanent access to the portal vein in rats: an experimental model. Eur Surg Res 32: 203-206, 2000.
19. Hall SE, Bolton TM, Hetenyi G, Jr. The effect of bran on glucose kinetics and plasma insulin in non-insulin-dependent diabetes mellitus. Diabetes Care 3: 520-525, 1980.
20. Hamilton-Wessler M, Bergman RN, Halter JB, Watanabe RM, Donovan CM. The role of liver glucosensors in the integrated sympathetic response induced by deep hypoglycemia in dogs. Diabetes 43: 1052-1060, 1994.
21. Hevener AL, Bergman RN, Donovan CM. Hypoglycemic detection does not occur in the hepatic artery or liver: findings consistent with a portal vein glucosensor locus. Diabetes 50: 399-403, 2001.
22. Hücking K, Watanabe RM, Stefanovski D, Bergman RN. OGTTderived measures of insulin sensitivity are confounded by factors other than insulin sensitivity itself. Obesity (Silver Spring) 16: 1938-1945, 2008.
23. Ionut V, Hucking K, Liberty IF, Bergman RN. Synergistic effect of portal glucose and glucagon-like peptide-1 to lower systemic glucose and stimulate counter-regulatory hormones. Diabetologia 48: 967-975, 2005.
24. Ionut V, Liberty IF, Hucking K, Lottati M, Stefanovski D, Zheng D, Bergman RN. Exogenously imposed postprandial-like rises in systemic glucose and GLP-1 do not produce an incretin effect, suggesting an indirect mechanism of GLP-1 action. Am J Physiol Endocrinol Metab 291: E779-E785, 2006.
25. Ionut V, Stefanovski D, Lottati M, Kirkman E, Zheng D, Bergman RN. Portal GLP-1 produces an insulin-independent reduction in glycemia by increasing extrahepatic glucose disposal without changing net hepatic glucose production (Abstract). American Diabetes Association 66th Scientific Sessions, 2006.
26. Johnson KM, Edgerton DS, Rodewald T, Scott M, Farmer B, Neal D, Cherrington AD. Intraportal GLP-1 infusion increases nonhepatic glucose utilization without changing pancreatic hormone levels. Am J Physiol Endocrinol Metab 293: E1085-E1091, 2007.
27. Johnson KM, Edgerton DS, Rodewald T, Scott M, Farmer B, Neal D, Cherrington AD. Intraportally delivered GLP-1, in the presence of hyperglycemia induced via peripheral glucose infusion, does not change whole body glucose utilization. Am J Physiol Endocrinol Metab 294: E380-E384, 2008.
28. Kaiser GM, Fruhauf NR, Broelsch CE. New surgical technique for portal venous port system in Swine. Eur Surg Res 37: 298-301, 2005.
29. Kim SP, Catalano KJ, Hsu IR, Chiu JD, Richey JM, Bergman RN. Nocturnal free fatty acids are uniquely elevated in the longitudinal development of diet-induced insulin resistance and hyperinsulinemia. Am J Physiol Endocrinol Metab 292: E1590-E1598, 2007.
30. Kim SP, Ellmerer M, Van Citters GW, Bergman RN. Primacy of hepatic insulin resistance in the development of the metabolic syndrome induced by an isocaloric moderate-fat diet in the dog. Diabetes 52: 2453-2460, 2003.
31. Krssak M, Brehm A, Bernroider E, Anderwald C, Nowotny P, Dalla MC, Cobelli C, Cline GW, Shulman GI, Waldhausl W, Roden M. Alterations in postprandial hepatic glycogen metabolism in type 2 diabetes. Diabetes 53: 3048-3056, 2004.
32. Lam TK. Brain Glucose Metabolism Controls Hepatic Glucose and Lipid Production. Cellscience 3: 63-69, 2007.
33. Lippi D, Caleri D, Bucalossi A, Rotella CM. The role of liver in glucose homeostasis in type 2 diabetes: the modernity of Claude Bernard's studies. Diabetes Metab Rev 10: 63-74, 1994.
34. Lottati M, Kolka CM, Stefanovski D, Kirkman EL, Bergman RN. Greater omentectomy improves insulin sensitivity in nonobese dogs. Obesity (Silver Spring) 17: 674-680, 2009.
35. Ludvik B, Nolan JJ, Roberts A, Baloga J, Joyce M, Bell JM, Olefsky JM. A noninvasive method to measure splanchnic glucose uptake after oral glucose administration. J Clin Invest 95: 2232-2238, 1995.
36. Ludvik B, Nolan JJ, Roberts A, Baloga J, Joyce M, Bell JM, Olefsky JM. Evidence for decreased splanchnic glucose uptake after oral glucose administration in non-insulin-dependent diabetes mellitus. J Clin Invest 100: 2354-2361, 1997.
37. McGuinness OP, Myers SR, Neal D, Cherrington AD. Chronic hyperinsulinemia decreases insulin action but not insulin sensitivity. Metabolism 39: 931-937, 1990.
38. Meyer C, Dostou J, Nadkarni V, Gerich J. Effects of physiological hyperinsulinemia on systemic, renal, and hepatic substrate metabolism. Am J Physiol Renal Physiol 275: F915-F921, 1998.
39. Meyer C, Dostou JM, Welle SL, Gerich JE. Role of human liver, kidney, and skeletal muscle in postprandial glucose homeostasis. Am J Physiol Endocrinol Metab 282: E419-E427, 2002.
40. Moore MC, Cherrington AD, Wasserman DH. Regulation of hepatic and peripheral glucose disposal. Best Pract Res Clin Endocrinol Metab 17: 343-364, 2003.
41. Muratoglu M, Kuyumjian J, Kalant N. First-pass hepatic uptake and utilization of glucose in the rat. Biochem J 233: 245-248, 1986.
42. Myers SR, Biggers DW, Neal DW, Cherrington AD. Intraportal glucose delivery enhances the effects of hepatic glucose load on net hepatic glucose uptake in vivo. J Clin Invest 88: 158-167, 1991.
43. Myers SR, McGuinness OP, Neal DW, Cherrington AD. Intraportal glucose delivery alters the relationship between net hepatic glucose uptake and the insulin concentration. J Clin Invest 87: 930-939, 1991.
44. Nakabayashi H, Nishizawa M, Nakagawa A, Takeda R, Niijima A. Vagal hepatopancreatic reflex effect evoked by intraportal appearance of tGLP-1. Am J Physiol Endocrinol Metab 271: E808-E813, 1996.
45. Pagliassotti MJ, Cherrington AD. Regulation of net hepatic glucose uptake in vivo. Annu Rev Physiol 54: 847-860, 1992.
46. Park KS, Rhee BD, Lee KU, Lee HK, Koh CS, Min HK. Hyperglycemia per se can reduce plasma free fatty acid and glycerol levels in the acutely insulin-deficient dog. Metabolism 39: 595-597, 1990.
47. Radziuk J, McDonald TJ, Rubenstein D, Dupre J. Initial splanchnic extraction of ingested glucose in normal man. Metabolism 27: 657-669, 1978.
48. Saberi M, Bohland M, Donovan CM. The locus for hypoglycemic detection shifts with the rate of fall in glycemia: the role of portal-superior mesenteric vein glucose sensing. Diabetes 57: 1380-1386, 2008.
49. Shen X, Yao Z, Johnson T, Feeney WP, Jennings V, Xu SS, Liesch J, Tong X. A portal vein cannulation technique for drug discovery in mice. Lab Anim (NY) 37: 41-44, 2008.
50. Sindelar DK, Chu CA, Venson P, Donahue EP, Neal DW, Cherrington AD. Basal hepatic glucose production is regulated by the portal vein insulin concentration. Diabetes 47: 523-529, 1998.
51. Steele R, Bjerknes C, Rathgeb I, Altszuler N. Glucose uptake and production during the oral glucose tolerance test. Diabetes 17: 415-421, 1968.
52. Steil GM, Ader M, Moore DM, Rebrin K, Bergman RN. Transendothelial insulin transport is not saturable in vivo. No evidence for a receptor-mediated process. J Clin Invest 97: 1497-1503, 1996.
53. Zheng D, Ionut V, Mooradian V, Stefanovski D, Bergman RN. Exenatide sensitizes insulin-mediated whole-body glucose disposal and promotes uptake of exogenous glucose by the liver. Diabetes 58: 352-359, 2009.